Clinical Trials

Showing trials with last updates posted in 2026.

NCT07764510 | ENROLLING_BY_INVITATION | NA
90 participants

Heart2Heart for Teens With CHD

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2026-08-18
Completion:
2028-07-31
Conditions
  • Congenital Heart Disease
  • Health Behavior
Interventions
  • BEHAVIORAL
No Results Yet
NCT07763223 | COMPLETED | NA
10 participants

Sub-junctional Pinhole Technique

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2024-06-30
Completion:
2025-04-25
Conditions
  • Periodontal Intrabony Defects
  • Stage III Grade B Periodontitis
Interventions
  • PROCEDURE
No Results Yet
NCT07763210 | NOT_YET_RECRUITING | PHASE2
59 participants

Lazarus: IT Therapy for ICANS

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2026-10-01
Completion:
2029-10-01
Conditions
  • Non-hodgkin Lymphoma
Interventions
  • DRUG
No Results Yet
NCT07762703 | NOT_YET_RECRUITING | PHASE1/PHASE2
10 participants

Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2026-09-30
Completion:
2030-09-30
Conditions
  • Triple-Negative Breast Cancer (TNBC)
Interventions
  • DRUG
No Results Yet
NCT07725835 | NOT_YET_RECRUITING | NA
30 participants

Effect of FPP on Cutaneous Barrier Integrity

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2026-09-30
Completion:
2028-04-30
Conditions
  • Skin Barrier Dysfunction
  • Healthy Volunteers
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT07724457 | NOT_YET_RECRUITING | PHASE2/PHASE3
271 participants

Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-19
Start Date:
2026-10-30
Completion:
2033-11-01
Conditions
  • Recurrent Burkitt Lymphoma
  • Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
  • Refractory Burkitt Lymphoma
  • Refractory High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page